menu_open Columnists
We use cookies to provide some features and experiences in QOSHE

More information  .  Close

FDA backs away from RFK Jr.’s claims about drug’s promise for autism patients

18 0
10.03.2026

FDA backs away from RFK Jr.’s claims about drug’s promise for autism patients

Food and Drug Administration Commissioner Marty Makary said in September he was changing leucovorin’s label because it could help “hundreds of thousands” of children with the neurological condition.

FDA Commissioner Marty Makary speaks alongside President Donald........

© Politico